WallStreetZenWallStreetZen

NASDAQ: LYEL
Lyell Immunopharma Inc Stock Ownership - Who owns Lyell Immunopharma?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Lyell Immunopharma Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Richard KlausnerDirector2023-08-1558,020$2.28
$132.29kSell

1 of 1

LYEL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LYEL insiders and whales buy or sell their stock.

LYEL Shareholders

What type of owners hold Lyell Immunopharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Robert Nelsen14.33%36,412,716$79.02MInsider
Arch Venture Partners Ix LLC14.33%36,412,716$79.02MInsider
Glaxosmithkline PLC11.91%30,253,189$65.65MInsider
Mwg Management Ltd7.93%20,162,332$43.75MInstitution
Orland Properties Ltd5.94%15,093,969$32.75MInstitution
Blackrock Inc5.63%14,302,220$31.04MInstitution
Vanguard Group Inc5.35%13,604,027$29.52MInstitution
Richard Klausner3.41%8,664,556$18.80MInsider
Foresite Capital Management Iv LLC3.28%8,325,000$18.07MInstitution
Wuxi Apptec Co Ltd3.22%8,180,678$17.75MInstitution

1 of 3

LYEL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LYEL51.66%46.21%Net Selling
IGMS37.27%54.63%Net BuyingNet Buying
GHRS56.89%0.00%
OLMA71.71%28.29%Net BuyingNet Selling
ORIC70.31%29.69%Net SellingNet Selling
View Top Biotech Stocks

Lyell Immunopharma Stock Ownership FAQ

Who owns Lyell Immunopharma?

Lyell Immunopharma (NASDAQ: LYEL) is owned by 51.66% institutional shareholders, 46.21% Lyell Immunopharma insiders, and 2.14% retail investors. Robert Nelsen is the largest individual Lyell Immunopharma shareholder, owning 36.41M shares representing 14.33% of the company. Robert Nelsen's Lyell Immunopharma shares are currently valued at $79.02M.

If you're new to stock investing, here's how to buy Lyell Immunopharma stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.